What’s new in the renin-angiotensin system?Structure of angiotensin I-converting enzyme

被引:0
|
作者
E. D. Sturrock
R. Natesh
J. M. van Rooyen
K. R. Acharya
机构
[1] University of Cape Town,Division of Medical Biochemistry, Faculty of Health Sciences
[2] University of Bath,Department of Biology and Biochemistry
关键词
Metallopeptidase; angiotensin I-converting enzyme; angiotensin converting enzyme homologue; neurolysin; carboxypeptidase; structure-based drug design;
D O I
暂无
中图分类号
学科分类号
摘要
Angiotensin-converting enzyme (ACE) is a zinc- and chloride-dependent metallopeptidase that plays a vital role in the metabolism of biologically active peptides. Until recently, much of the inhibitor design and mechanism of action of this ubiquitous enzyme was based on the structures of carboxypeptidase A and thermolysin. When compared to the recently solved structures of the testis isoform of ACE (tACE) and its Drosophila homologue (AnCE), carboxypeptidase A showed little structural homology outside of the active site, while thermolysin revealed significant but less marked overall similarity. The ellipsoid-shaped structure of tACE, which has a preponderance of α-helices, is characterised by a core channel that has a constriction approximately 10 Å from its opening where the zinc-binding active site is located. Comparison of the native protein with the inhibitor-bound form (lisinopril-tACE) does not reveal any striking differences in the conformation of the inhibitor binding site, disfavouring an open and closed configuration. However, the inhibitor complex does provide insights into the network of hydrogen-bonding and ionic interactions in the active site as well as the mechanism of ACE substrate hydrolysis. The three-dimensional structure of ACE now paves the way for the rational design of a new generation of domain-selective ACE inhibitors.
引用
收藏
页码:2677 / 2686
页数:9
相关论文
共 50 条
  • [2] What’s new in the renin-angiotensin system?What’s new in the renin-angiotensin system?
    A. I. Smith
    A. J. Turner
    Cellular and Molecular Life Sciences CMLS, 2004, 61 (21): : 2675 - 2676
  • [3] What’s new in the renin-angiotensin system?Physiological roles of angiotensin-converting enzyme 2
    U. Danilczyk
    U. Eriksson
    G. Y. Oudit
    J. M. Penninger
    Cellular and Molecular Life Sciences CMLS, 2004, 61 : 2714 - 2719
  • [4] Structure of angiotensin I-converting enzyme
    Sturrock, ED
    Natesh, R
    van Rooyen, JM
    Acharya, KR
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2004, 61 (21) : 2677 - 2686
  • [5] Angiotensin-converting enzyme 2 and new insights into the renin-angiotensin system
    Lambert, Daniel W.
    Hooper, Nigel M.
    Turner, Anthony J.
    BIOCHEMICAL PHARMACOLOGY, 2008, 75 (04) : 781 - 786
  • [6] What’s new in the renin-angiotensin system?Angiotensin-converting enzyme 2: a functional receptor for SARS coronavirus
    J. H. Kuhn
    W. Li
    H. Choe
    M. Farzan
    Cellular and Molecular Life Sciences CMLS, 2004, 61 : 2738 - 2743
  • [7] What’s new in the renin-angiotensin system?Angiotensin-converting enzyme-2: a molecular and cellular perspective
    F. J. Warner
    A. I. Smith
    N. M. Hooper
    A. J. Turner
    Cellular and Molecular Life Sciences CMLS, 2004, 61 : 2704 - 2713
  • [8] EFFECTS OF ANGIOTENSIN-I CONVERTING ENZYME-INHIBITORS ON RENIN-ANGIOTENSIN SYSTEM
    KOMORI, T
    TAKADA, T
    HIGASHIO, T
    ABE, Y
    YAMAMOTO, K
    FOLIA PHARMACOLOGICA JAPONICA, 1980, 76 (04) : P90 - P90
  • [9] What's new in the renin-angiotensin system?
    Smith, AI
    Turner, AJ
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2004, 61 (21) : 2675 - 2676
  • [10] RENIN, RENIN SUBSTRATE, AND ANGIOTENSIN I-CONVERTING ENZYME IN LYMPH OF RATS
    HORKY, K
    ROJOORTE.JM
    RODRIGUEZ, J
    BOUCHER, R
    GENEST, J
    AMERICAN JOURNAL OF PHYSIOLOGY, 1971, 220 (02): : 307 - +